FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sander Robins

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Organizations

United States Department of Veterans Affairs

Geographic Areas

United States

Co-author Network

Publications

TOP 3
Sander J Robins; Robert W Brocia; Asya Lyass; Joseph M Massaro; Ramachandran S Vasan
Plasma lipid transfer proteins and cardiovascular disease. The Framingham Heart Study.
Meredith C Foster; Shih-Jen Hwang; Joseph M Massaro; Udo Hoffmann; Ian H DeBoer; Sander J Robins; Ramachandran S Vasan; Caroline S Fox
Association of subcutaneous and visceral adiposity with albuminuria: the Framingham Heart Study.
Gina M Peloso; Serkalem Demissie; Dorothea Collins; Daniel B Mirel; Stacey B Gabriel; L Adrienne Cupples; Sander J Robins; Ernst J Schaefer; Margaret E Brousseau
Common genetic variation in multiple metabolic pathways influences susceptibility to low HDL-cholesterol and coronary heart disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sander Robins (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sander J Robins; Robert W Brocia; Asya Lyass; Joseph M Massaro; Ramachandran S Vasan
Plasma lipid transfer proteins and cardiovascular disease. The Framingham Heart Study.
Atherosclerosis 2013;228(1):230-6.
2011: Meredith C Foster; Shih-Jen Hwang; Joseph M Massaro; Udo Hoffmann; Ian H DeBoer; Sander J Robins; Ramachandran S Vasan; Caroline S Fox
Association of subcutaneous and visceral adiposity with albuminuria: the Framingham Heart Study.
Obesity (Silver Spring, Md.) 2011;19(6):1284-9.
2010: Gina M Peloso; Serkalem Demissie; Dorothea Collins; Daniel B Mirel; Stacey B Gabriel; L Adrienne Cupples; Sander J Robins; Ernst J Schaefer; Margaret E Brousseau
Common genetic variation in multiple metabolic pathways influences susceptibility to low HDL-cholesterol and coronary heart disease.
Journal of lipid research 2010;51(12):3524-32.
2010: Sarah R Preis; Joseph M Massaro; Sander J Robins; Udo Hoffmann; Ramachandran S Vasan; Thomas Irlbeck; James B Meigs; Patrice Sutherland; Ralph B D'Agostino; Christopher J O'Donnell; Caroline S Fox
Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study.
Obesity (Silver Spring, Md.) 2010;18(11):2191-8.
2009: Raghava S Velagaleti; Joseph M Massaro; Ramachandran S Vasan; Sander J Robins; William B Kannel; Daniel Levy
Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study.
Circulation 2009;120(23):2345-51.
2008: William B Kannel; Ramachandran S Vasan; Michelle J Keyes; Lisa M Sullivan; Sander J Robins
Usefulness of the triglyceride-high-density lipoprotein versus the cholesterol-high-density lipoprotein ratio for predicting insulin resistance and cardiometabolic risk (from the Framingham Offspring Cohort).
The American journal of cardiology 2008;101(4):497-501.
2008: Sander J Robins; Dorothea Collins; Judith R McNamara; Hanna E Bloomfield
Body weight, plasma insulin, and coronary events with gemfibrozil in the Veterans Affairs High-Density Lipoprotein Intervention Trial (VA-HIT).
Atherosclerosis 2008;196(2):849-55.
2008: Bela F Asztalos; Dorothea Collins; Katalin V Horvath; Hanna E Bloomfield; Sander J Robins; Ernst Schaefer
Relation of gemfibrozil treatment and high-density lipoprotein subpopulation profile with cardiovascular events in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
Metabolism: clinical and experimental 2008;57(1):77-83.
2007: Angeliki Georgopoulos; Hanna E Bloomfield; Dorothea Collins; Margaret E Brousseau; Jose Ordovas; John J O'Connor; Sander J Robins; Ernst Schaefer
Codon 54 polymorphism of the fatty acid binding protein (FABP) 2 gene is associated with increased cardiovascular risk in the dyslipidemic diabetic participants of the Veterans Affairs HDL intervention trial (VA-HIT).
Atherosclerosis 2007;194(1):169-74.
2007: Emelia Benjamin; Josée Dupuis; Martin G Larson; Kathryn L Lunetta; Sarah L Booth; Diddahally R Govindaraju; Sekar Kathiresan; John F Keaney; Michelle J Keyes; Jing-Ping Lin; James B Meigs; Sander J Robins; Jian Rong; Renate Schnabel; Joseph A Vita; Thomas J Wang; Peter W F Wilson; Philip A Wolf; Ramachandran S Vasan
Genome-wide association with select biomarker traits in the Framingham Heart Study.
BMC medical genetics 2007;8 Suppl 1():S11.
2006: Bela F Asztalos; Serkalem Demissie; L Adrienne Cupples; Dorothea Collins; Caitlin E Cox; Katalin V Horvath; Hanna E Bloomfield; Sander J Robins; Ernst Schaefer
LpA-I, LpA-I:A-II HDL and CHD-risk: The Framingham Offspring Study and the Veterans Affairs HDL Intervention Trial.
Atherosclerosis 2006;188(1):59-67.
2006: Sander J Robins; Hanna E Bloomfield
Fibric acid derivatives in cardiovascular disease prevention: results from the large clinical trials.
Current opinion in lipidology 2006;17(4):431-9.
2006: E Shyong Tai; Dorothea Collins; Sander J Robins; John J O'Connor; Hanna E Bloomfield; Jose Ordovas; Ernst Schaefer; Margaret E Brousseau
The L162V polymorphism at the peroxisome proliferator activated receptor alpha locus modulates the risk of cardiovascular events associated with insulin resistance and diabetes mellitus: the Veterans Affairs HDL Intervention Trial (VA-HIT).
Atherosclerosis 2006;187(1):153-60.
2006: James D Otvos; Dorothea Collins; David S Freedman; Irina Shalaurova; Ernst Schaefer; Judith R McNamara; Hanna E Bloomfield; Sander J Robins
Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
Circulation 2006;113(12):1556-63.
2006: Sekar Kathiresan; James D Otvos; Lisa M Sullivan; Michelle J Keyes; Ernst Schaefer; Peter W F Wilson; Ralph B D'Agostino; Ramachandran S Vasan; Sander J Robins
Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study.
Circulation 2006;113(1):20-9.
2005: Bela F Asztalos; Dorothea Collins; L Adrienne Cupples; Serkalem Demissie; Katalin V Horvath; Hanna E Bloomfield; Sander J Robins; Ernst Schaefer
Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(10):2185-91.
2004: Margaret E Brousseau; Allison L Goldkamp; Dorothea Collins; Serkalem Demissie; Allison C Connolly; L Adrienne Cupples; Jose Ordovas; Hanna E Bloomfield; Sander J Robins; Ernst Schaefer
Polymorphisms in the gene encoding lipoprotein lipase in men with low HDL-C and coronary heart disease: the Veterans Affairs HDL Intervention Trial.
Journal of lipid research 2004;45(10):1885-91.
2003: Sander J Robins
Cardiovascular disease with diabetes or the metabolic syndrome: should statins or fibrates be first line lipid therapy?
Current opinion in lipidology 2003;14(6):575-83.
2003: Sander J Robins; Hanna Bloomfield Rubins; Fred H Faas; Ernst Schaefer; Marshall B Elam; James W Anderson; Dorothea Collins
Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT).
Diabetes care 2003;26(5):1513-7.
2002: Hanna Bloomfield Rubins; Sander J Robins; Dorothea Collins; David B Nelson; Marshall B Elam; Ernst Schaefer; Fred H Faas; James W Anderson
Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT).
Archives of internal medicine 2002;162(22):2597-604.
2002: Margaret E Brousseau; John J O'Connor; Jose Ordovas; Dorothea Collins; James D Otvos; Tatyana Massov; Judith R McNamara; Hanna Bloomfield Rubins; Sander J Robins; Ernst Schaefer
Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(7):1148-54.
2002: Joao A Gomes; Sander J Robins; Viken L Babikian
Treatment of lipid disorders after stroke.
Current atherosclerosis reports 2002;4(4):304-10.
2002: John A Nyman; Melissa S Martinson; David Nelson; Sean Nugent; Dorothea Collins; Janet Wittes; Carol L Fye; Timothy J Wilt; Sander J Robins; Hanna Bloomfield Rubins
Cost-effectiveness of gemfibrozil for coronary heart disease patients with low levels of high-density lipoprotein cholesterol: the Department of Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial.
Archives of internal medicine 2002;162(2):177-82.
2001: Sander J Robins
Targeting low high-density lipoprotein cholesterol for therapy: lessons from the Veterans Affairs High-density Lipoprotein Intervention Trial.
The American journal of cardiology 2001;88(12A):19N-23N.
2001: Hanna Bloomfield Rubins; J Davenport; Viken L Babikian; L M Brass; Dorothea Collins; L Wexler; S Wagner; V Papademetriou; G Rutan; Sander J Robins
Reduction in stroke with gemfibrozil in men with coronary heart disease and low HDL cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT).
Circulation 2001;103(23):2828-33.
2001: Sander J Robins; Dorothea Collins; Janet Wittes; V Papademetriou; P C Deedwania; Ernst Schaefer; Judith R McNamara; M L Kashyap; J M Hershman; L F Wexler; Hanna Bloomfield Rubins
Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2001;285(12):1585-91.
2001: Margaret E Brousseau; Marek Bodzioch; Ernst Schaefer; Allison L Goldkamp; Danuta Kielar; M Probst; Jose Ordovas; Charalampos Aslanidis; Karl J Lackner; Hanna Bloomfield Rubins; Dorothea Collins; Sander J Robins; P W Wilson; Gerd Schmitz
Common variants in the gene encoding ATP-binding cassette transporter 1 in men with low HDL cholesterol levels and coronary heart disease.
Atherosclerosis 2001;154(3):607-11.
2000: Hanna Bloomfield Rubins; Sander J Robins
Conclusions from the VA-HIT study.
The American journal of cardiology 2000;86(5):543-4.
2000: Hanna Bloomfield Rubins; Dorothea Collins; Sander J Robins
The VA HDL intervention trial: clinical implications.
European heart journal 2000;21(14):1113-5.
1999: Hanna Bloomfield Rubins; Sander J Robins; Dorothea Collins; C L Fye; James W Anderson; Marshall B Elam; Fred H Faas; E Linares; Ernst Schaefer; G Schectman; Timothy J Wilt; Janet Wittes
Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group.
The New England journal of medicine 1999;341(6):410-8.
1998: V Papademetriou; P Narayan; Hanna Bloomfield Rubins; Dorothea Collins; Sander J Robins
Influence of risk factors on peripheral and cerebrovascular disease in men with coronary artery disease, low high-density lipoprotein cholesterol levels, and desirable low-density lipoprotein cholesterol levels. HIT Investigators. Department of Veterans Affairs HDL Intervention Trial.
American heart journal 1998;136(4 Pt 1):734-40.
1997: Timothy J Wilt; Hanna Bloomfield Rubins; Sander J Robins; W A Riley; Dorothea Collins; M Elam; G Rutan; James W Anderson
Carotid atherosclerosis in men with low levels of HDL cholesterol.
Stroke; a journal of cerebral circulation 1997;28(10):1919-25.
1996: Hanna Bloomfield Rubins; Sander J Robins; Dorothea Collins
The Veterans Affairs High-Density Lipoprotein Intervention Trial: baseline characteristics of normocholesterolemic men with coronary artery disease and low levels of high-density lipoprotein cholesterol. Veterans Affairs Cooperative Studies Program High-Density Lipoprotein Intervention Trial Study Group.
The American journal of cardiology 1996;78(5):572-5.
1996: Timothy J Wilt; Hanna Bloomfield Rubins; Dorothea Collins; T Z O'Connor; G H Rutan; Sander J Robins
Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
Archives of internal medicine 1996;156(11):1181-8.
1995: Hanna Bloomfield Rubins; Sander J Robins; Dorothea Collins; A Iranmanesh; Timothy J Wilt; D Mann; M Mayo-Smith; F H Faas; Marshall B Elam; G H Rutan
Distribution of lipids in 8,500 men with coronary artery disease. Department of Veterans Affairs HDL Intervention Trial Study Group.
The American journal of cardiology 1995;75(17):1196-201.
1994: Judith R McNamara; C Huang; T Massov; Elizabeth Leary; G Russell Warnick; Hanna Bloomfield Rubins; Sander J Robins; Ernst Schaefer
Modification of the dextran-Mg2+ high-density lipoprotein cholesterol precipitation method for use with previously frozen plasma.
Clinical chemistry 1994;40(2):233-9.
1993: Hanna Bloomfield Rubins; Sander J Robins; M K Iwane; William E Boden; Marshall B Elam; C L Fye; D J Gordon; Ernst Schaefer; G Schectman; Janet Wittes
Rationale and design of the Department of Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial (HIT) for secondary prevention of coronary artery disease in men with low high-density lipoprotein cholesterol and desirable low-density lipoprotein cholesterol.
The American journal of cardiology 1993;71(1):45-52.
1992: Hanna Bloomfield Rubins; Sander J Robins
Effect of reduction of plasma triglycerides with gemfibrozil on high-density-lipoprotein-cholesterol concentrations.
Journal of internal medicine 1992;231(4):421-6.